The following articles have been tagged with "David_brennan":
Business & Money: 31 Jan 13
Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday that net profits sank 37 percent last year, hit by the expiry of drug patents and "tough" markets, and warned revenues would fall further in 2013.
READ »
Business & Money: 25 Oct 12
The Anglo-Swedish pharmaceutical manufacturer AstraZeneca announced on Thursday that third quarter net earnings had dropped 56 percent on the back of a loss of exclusivity on several brands.
READ »
Business & Money: 28 Aug 12
Pharmaceutical giant AstraZeneca on Tuesday announced that Frenchman Pascal Soriot would take over as the Anglo-Swedish company's new chief executive.
READ »
Business & Money: 26 Apr 12
The Anglo-Swedish pharmaceutical manufacturer Astra Zeneca announced on Thursday that its CEO David Brennan was leaving, while at the same time reporting a 44 percent fall in their first quarter profits.
READ »
Business & Money: 21 Jul 11
Anglo-Swedish pharmaceuticals firm AstraZeneca announced on Thursday that the US Food and Drug Administration (FDA) has approved its Brilinta heart drug for use on patients in the United States.
READ »
Business & Money: 27 Jan 11
Anglo-Swedish drugs giant AstraZeneca on Thursday announced net profits for 2010 of more than $8.0 billion, a seven percent rise on the previous year on the back of higher sales of its cholesterol treatment Crestor.
READ »
Science & Technology: 5 Dec 10
A new Swedish study has revealed that respondents from six countries believe that China will become the world's most innovative country in 10 years, followed by India and the US.
READ »
Business & Money: 28 Oct 10
Anglo-Swedish pharmaceutical giant AstraZeneca on Thursday reported a dip in third-quarter net profits as competition from generic drugmakers, restructuring costs and massive legal charges took their toll.
READ »
Business & Money: 29 Jul 10
Anglo-Swedish pharmaceutical company AstraZeneca said on Thursday that second-quarter net profit jumped to $2.1 billion (15.35 billion kronor) on strong performance across emerging markets and key drug sales.
READ »
Business & Money: 29 Apr 10
Anglo Swedish pharmaceuticals firm AstraZeneca reported a first quarter profit climb of 29 percent on Thursday on the back of a "strong" performance in emerging markets and sales of key products.
READ »
Business & Money: 28 Jan 10
Anglo-Swedish drugmaker AstraZeneca plans to slash 8,000 more jobs worldwide by 2014, continuing its efforts to cut costs despite rising profits, the company announced on Thursday.
READ »
Business & Money: 30 Jul 09
Swedish-Anglo pharmaceuticals giant AstraZeneca reported a 23.4 percent hike in interim net profits on Thursday despite the global recession.
READ »
Business & Money: 29 Jan 09
Anglo-Swedish drugmaker AstraZeneca on Thursday reported 2008 annual net profits were up 9 percent to $6.10 billion, but that the company plans to shed 7,000 more jobs by 2013.
READ »
Business & Money: 30 Oct 08
Anglo-Swedish pharmaceuticals giant AstraZeneca posted third quarter profits on Thursday up 28.8 percent on the same period last year.
READ »
Business & Money: 28 Mar 08
The wages of managing directors in Sweden's top stock exchange listed companies continued to rise sharply last year with many firms posting record profits.
READ »
Business & Money: 31 Jan 08
Pharmaceuticals giant AstraZeneca saw its net profit fall 7.2 percent last year to $5.63 billion (€3.79 billion), owing partly to a major restructuring.
READ »
Business & Money: 1 Nov 07
Anglo-Swedish pharmaceuticals giant AstraZeneca said Thursday that group net profit fell 15.4 percent in the third quarter as higher costs weighed.
READ »
Business & Money: 11 Jan 07
Anglo-Swedish drugs giant AstraZeneca has announced a major collaboration with Bristol-Myers Squibb to develop and commercialise two diabetes drugs.
READ »
Business & Money: 26 Oct 06
The announcement of a 30 percent leap in profits from Anglo-Swedish pharmaceuticals giant AstraZeneca was marred on Thursday by the disclosure that the company has ended development of a stroke drug after it failed the final stages of clinical trials.
READ »
Business & Money: 27 Jul 06
The Anglo-Swedish drugs giant has reported a 33.5 percent leap in net profits for the first half of 2006.
READ »
Business & Money: 4 May 06
Shares in the Anglo-Swedish pharma company are expected to fall on Thursday after it announces that it will abandon development of its Galida diabetes product.
READ »
Business & Money: 14 Feb 06
The Anglo-Swedish drugs giant AstraZeneca said on Tuesday that it had decided to withdraw its Exanta treatment for blood clotting owing to concerns about the safety of the tablet drug.
READ »
Business & Money: 28 Jul 05
Anglo-Swedish drugs giant AstraZeneca replaces chief executive Tom McKillop, as it announces a profits surge of 55 percent for the second quarter. McKillop will be replaced by the company's American chief.
READ »
Latest news about gambling laws and online gambling sites in Sweden
News provided by GamingZion: Your global online gambling directory
More news from Germany at thelocal.de
More news from France at thelocal.fr
More news from Norway at thelocal.no
More news from Switzerland at thelocal.ch
Register now for:
> Free use of noticeboard
> Special discounts
> Weekly news roundup
> Unlimited use of discuss
Be British, be sincere and be bold »
"Sweden is a veritable smorgåsbord for UK business. I see our work as a bit like a kind of dragon’s den for both for larger and smaller British companies. It is about matching the UK companies, not with cash, but with Swedish market opportunities." READ »